Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia.
Bachmeyer
Claude
C
Maury
Jacqueline
J
Parrot
Antoine
A
Bachir
Dora
D
Stankovic
Katia
K
Girot
Robert
R
Lionnet
François
F
D000328:Adult; D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D006461:Hemolysis; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab